Nanoviricides (NNVC) Current Assets (2011 - 2026)

Nanoviricides has disclosed Current Assets across 16 years of filings, most recently posting $3.4 million for Q1 2026.

• In Q1 2026, Current Assets rose 23.86% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $3.4 million (up 23.86% YoY), while the FY2025 annual figure was $1.7 million, down 66.39% from the prior year.
• Current Assets came in at $3.4 million for Q1 2026 at Nanoviricides, down from $5.3 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $15.9 million in Q1 2022 to a low of $1.3 million in Q3 2025.
• Average Current Assets over 5 years is $6.9 million, with a median of $5.3 million recorded in 2025.
• The largest YoY upside for Current Assets was 30.08% in 2025 against a maximum downside of 69.01% in 2025.
• Over 5 years, Current Assets stood at $11.6 million in 2022, then slumped by 53.97% to $5.3 million in 2023, then declined by 23.43% to $4.1 million in 2024, then surged by 30.08% to $5.3 million in 2025, then sank by 36.22% to $3.4 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $3.4 million in Q1 2026, $5.3 million in Q4 2025, and $1.3 million in Q3 2025.